Tyagi, A., Sandhya, S., Sharma, P., Saxena, S., Sharma, R., Mithra, S. A., … Gaikwad, K. (2019). The genome size of clusterbean (Cyamopsis tetragonoloba) is significantly smaller compared to its wild relatives as estimated by flow cytometry. Gene. https://doi.org/10.1016/j.gene.2019.02.090 (Original work published 2019)

Haymaker, C., Kim, D., Uemura, M., Vence, L., Phillip, A., McQuail, N., … Diab, A. (2017). Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade. Cancer Immunology Research, 5(2), 100-105. https://doi.org/10.1158/2326-6066.CIR-16-0223

Zamarin, D., Holmgaard, R., Ricca, J., Plitt, T., Palese, P., Sharma, P., … Allison, J. (2017). Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Nature Communications, 8, 14340. https://doi.org/10.1038/ncomms14340 (Original work published 2017)

Morris, V., Salem, M., Nimeiri, H., Iqbal, S., Singh, P., Ciombor, K., … Eng, C. (2017). Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. The Lancet. Oncology, 18(4), 446-453. https://doi.org/10.1016/S1470-2045(17)30104-3

Bennett, C., Vakil, N., Bergman, J., Harrison, R., Odze, R., Vieth, M., … Jankowski, J. (2012). Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology, 143(2), 336-46. https://doi.org/10.1053/j.gastro.2012.04.032

Gao, J., Ward, J., Pettaway, C., Shi, L., Subudhi, S., Vence, L., … Sharma, P. (2017). VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer. Nature Medicine, 23(5), 551-555. https://doi.org/10.1038/nm.4308

Reilley, M., Bailey, A., , Janku, F., Naing, A., Falchook, G., … Hong, D. Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies. Journal for Immunotherapy of Cancer, 5, 35. https://doi.org/10.1186/s40425-017-0238-1 (Original work published 2017)

Boddu, P., Kantarjian, H., Garcia-Manero, G., Allison, J., Sharma, P., & Daver, N. (2018). The emerging role of immune checkpoint based approaches in AML and MDS. Leukemia & Lymphoma, 59(4), 790-802. https://doi.org/10.1080/10428194.2017.1344905

Reuben, A., Gittelman, R., Gao, J., Zhang, J., Yusko, E., Wu, C., … Zhang, J. (2017). TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence. Cancer Discovery, 7(10), 1088-1097. https://doi.org/10.1158/2159-8290.CD-17-0256

Wei, S., Levine, J., Cogdill, A., Zhao, Y., Anang, N., Andrews, M., … Allison, J. (2017). Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade. Cell, 170(6), 1120-1133.e17. https://doi.org/10.1016/j.cell.2017.07.024 (Original work published 2017)